Literature DB >> 22431160

IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia.

Zubair H Aghai1, Judy G Saslow, Kartik Mody, Riva Eydelman, Vishwanath Bhat, Gary Stahl, Kee Pyon, Vineet Bhandari.   

Abstract

BACKGROUND: Interferon-gamma (IFN-γ) and interferon-inducible protein of 10 kDa (IP-10) are potent inflammatory mediators and contribute to acute lung injury in adults. Recently, a potential role for IFN-γ and IP-10 in the pathogenesis of bronchopulmonary dysplasia (BPD) has been reported in animal models.
OBJECTIVE: To study the association between IFN-γ and IP-10 in tracheal aspirate (TA) and the development of BPD in premature infants. DESIGN/
METHODS: TA samples collected within 48 hr after birth from 79 mechanically ventilated premature neonates [gestational age (GA) <30 weeks (w), birth weight (BW) <1,250 g (g)] were analyzed. IFN-γ was measured in a subgroup of 38 infants by using a biochip multi-analyte immunoassay. The level of IP-10 was determined using a commercially available ELISA kit. Total protein in TA was measured by Bradford assay to correct for sampling related dilution. BPD was defined as the need of supplemental oxygen at 36 weeks postmenstrual age (PMA).
RESULTS: Twenty infants (GA 26.4 ± 1.9w, BW 860 ± 201 g) survived without BPD at 36 weeks PMA and 59 infants (GA 25.5 ± 1.5w, BW 751 ± 163 g) died before 36 weeks PMA or developed BPD. The mean IFN-γ level was higher in infants who died or developed BPD (9.7 ± 2.8 vs. 3.1 ± 1.1 pg/ml, P = 0.03). Similarly, the mean IP-10 level was higher in infants who died or developed BPD (63.4 ± 17.5 pg/ml) compared to those who survived without BPD (18.5 ± 7.5 pg/ml, P = 0.02).
CONCLUSIONS: Higher IFN-γ and IP-10 levels in TA samples are associated with the development of BPD or death in premature infants.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431160     DOI: 10.1002/ppul.22540

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  11 in total

1.  Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics.

Authors:  Fiammetta Piersigilli; TuKiet T Lam; Pamela Vernocchi; Andrea Quagliariello; Lorenza Putignani; Zubair H Aghai; Vineet Bhandari
Journal:  Metabolomics       Date:  2019-02-02       Impact factor: 4.290

2.  Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants.

Authors:  Charitharth Vivek Lal; Nelida Olave; Colm Travers; Gabriel Rezonzew; Kalsang Dolma; Alexandra Simpson; Brian Halloran; Zubair Aghai; Pragnya Das; Nirmal Sharma; Xin Xu; Kristopher Genschmer; Derek Russell; Tomasz Szul; Nengjun Yi; J Edwin Blalock; Amit Gaggar; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  JCI Insight       Date:  2018-03-08

3.  Antenatal Mesenchymal Stromal Cell Extracellular Vesicle Therapy Prevents Preeclamptic Lung Injury in Mice.

Authors:  Elizabeth S Taglauer; Angeles Fernandez-Gonzalez; Gareth R Willis; Monica Reis; Vincent Yeung; Xianlan Liu; Lawrence S Prince; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 7.748

4.  Single-Cell RNA Sequencing-Based Characterization of Resident Lung Mesenchymal Stromal Cells in Bronchopulmonary Dysplasia.

Authors:  Ivana Mižíková; Flore Lesage; Chanele Cyr-Depauw; David P Cook; Maria Hurskainen; Satu M Hänninen; Arul Vadivel; Pauline Bardin; Shumei Zhong; Olli Carpén; Barbara C Vanderhyden; Bernard Thébaud
Journal:  Stem Cells       Date:  2022-05-27       Impact factor: 5.845

Review 5.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Vineet Bhandari
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

Review 6.  Animal models of bronchopulmonary dysplasia. The term mouse models.

Authors:  Jessica Berger; Vineet Bhandari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-10       Impact factor: 5.464

7.  Adiponectin ameliorates hyperoxia-induced lung endothelial dysfunction and promotes angiogenesis in neonatal mice.

Authors:  Dilip Shah; Karmyodh Sandhu; Pragnya Das; Vineet Bhandari
Journal:  Pediatr Res       Date:  2021-03-25       Impact factor: 3.756

8.  The Airway Microbiome at Birth.

Authors:  Charitharth Vivek Lal; Colm Travers; Zubair H Aghai; Peter Eipers; Tamas Jilling; Brian Halloran; Waldemar A Carlo; Jordan Keeley; Gabriel Rezonzew; Ranjit Kumar; Casey Morrow; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

9.  Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Inhaled Nitric Oxide.

Authors:  Mandy Laube; Elena Amann; Ulrike Uhlig; Yang Yang; Hans W Fuchs; Michael Zemlin; Jean-Christophe Mercier; Rolf F Maier; Helmut D Hummler; Stefan Uhlig; Ulrich H Thome
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

10.  Hyperoxia exacerbates postnatal inflammation-induced lung injury in neonatal BRP-39 null mutant mice promoting the M1 macrophage phenotype.

Authors:  Mansoor A Syed; Vineet Bhandari
Journal:  Mediators Inflamm       Date:  2013-11-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.